Evanston Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-71,493
Closed -$6.38M 58
2015
Q4
$6.38M Buy
71,493
+132
+0.2% +$11.2K 2.23% 17
2015
Q3
$5.48M Buy
71,361
+2,491
+4% +$208K 1.81% 33
2015
Q2
$5.76M Buy
68,870
+2,166
+3% +$191K 1.89% 25
2015
Q1
$6.02M Sell
66,704
-5,867
-8% -$505K 1.97% 18
2014
Q4
$5.86M Sell
72,571
-5,293
-7% -$418K 2.07% 21
2014
Q3
$5.83M Buy
77,864
+1,161
+2% +$84.5K 1.98% 16
2014
Q2
$5.26M Sell
76,703
-414
-0.5% -$28.2K 1.82% 32
2014
Q1
$5.4M Sell
77,117
-14,514
-16% -$1.01M 1.93% 16
2013
Q4
$6.12M Sell
91,631
-5,681
-6% -$347K 2.31% 9
2013
Q3
$5.08M Buy
97,312
+894
+0.9% +$45.4K 2.04% 14
2013
Q2
$4.55M Buy
+96,418
New +$4.4M 2.02% 24

Other funds holding CAH

Evanston Advisors's CAH Position: Q1 2016 in Review

Evanston Advisors sold out of Cardinal Health (CAH) in Q1 2016, closing a stake of 71,493 shares — an estimated $6.38M sold.

Evanston Advisors first reported a position in CAH in Q2 2013 and held it in 11 quarters. The position peaked at $6.38M in Q4 2015. 792 funds tracked by Wall St. Rank hold CAH as of Q1 2016.

  • Evanston Advisors reported no remaining Cardinal Health position as of Q1 2016 after selling out during the quarter.
  • Evanston Advisors sold 71,493 Cardinal Health shares in Q1 2016, an estimated $6.38M.
  • Evanston Advisors first reported a position in Cardinal Health in Q2 2013 and held it in 11 quarters.
  • Evanston Advisors's Cardinal Health position peaked at $6.38M in Q4 2015.
  • 792 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2016.

Based on Evanston Advisors's 13F filing for Q1 2016, filed 2 May 2016.